Fiebre y exantema en un paciente joven: reacción a medicamentos con eosinofilia y síntomas sistémicos al alopurinol

Gallo Puelles, Francisco; Muñoz Jiménez, Alejandro; Velloso Feijoó, M Luisa; Leon Garcia, Mario; Rodriguez Montero, Sergio; Marenco de la Fuente, José Luis.
Reumatol. clín. (Barc.) ; 9(6): 379-380, nov.-dic. 2013. ilus
Artículo en Español | IBECS (España) | ID: ibc-116225

Documentos relacionados

  1. Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease.
  2. Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
  3. Unusual drug reaction with features of colchicine toxicity in a patient on colchicine and allopurinol.
  4. Formulation, Optimization, and Evaluation of Allopurinol-Loaded Bovine Serum Albumin Nanoparticles for Targeting Kidney in Management of Hyperuricemic Nephrolithiasis : Formulation, optimization, and evaluation of ABNPs for kidney targeting.
  5. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
  6. Allopurinol Prophylaxis: Safeguarding Against Liver Cirrhosis Complications.
  7. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
  8. [Acute life-threatening drug reactions of the skin].
  9. Acute kidney injury in allopurinol-induced DRESS syndrome: a case report of concurrent tubulointerstitial nephritis and kidney-limited necrotizing vasculitis
.
  10. Safety and efficacy of allopurinol in chronic kidney disease.